BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 13, 2019
View Archived Issues
In vivo research suggests E-cadherin drives metastasis
Read More
Bug likes bleach
Read More
Wharton's jelly-derived mesenchymal stem cells evaluated in chronic ischemic heart failure
Read More
GT Biopharma initiates enrollment in first-in-human study of GTB-3550
Read More
Navitor presents data from phase I program of NV-5138
Read More
Dahl-S model of hypertension associates higher cerebral blood flow with lower anxiety level
Read More
LCGA-17 peptide shows anxiolytic and antidepressant activity in zebrafish
Read More
BoNTANA Therapies describes nucleic acids encoding botulinum neurotoxins
Read More
CD47 single-domain antibodies patented by Shanghai Novamab Biopharmaceuticals
Read More
Adamed Pharma discovers dual 5-HT2A and 5-HT6 receptor antagonists
Read More
Fraunhofer-Gesellschaft identifies inhibitors of bacterial glutaminyl cyclases
Read More
New protein-arginine deiminase type-4 inhibitors synthesized at Nanjing TransThera Biosciences
Read More
Pharvaris announces financing to advance clinical development of HAE oral therapy
Read More
AgeneBio receives support for GABA-A alpha5 PAM program
Read More
Spinal SGK1 is involved in the development of morphine tolerance through NF-kB p65/NMDAR signaling
Read More
S100A9/TLR4 axis can be a target for the management of insulin deficiency
Read More
Red blood cell transfusions in anemic murine neonates cause necrotizing enterocolitis
Read More
CADPA multi-biomarker score identifies hidden risk of acute coronary syndromes
Read More
Phase I results of nivolumab, ipilimumab and nintedanib combination in advanced NSCLC presented
Read More
Study shows just how far precision target ID has yet to go
Read More
Phase III trial of Toca-511/Toca-FC in recurrent high-grade glioma misses primary endpoint
Read More
Ovid begins pivotal trial of OV-101 for Angelman syndrome
Read More
FDA approves Ibsrela for irritable bowel syndrome with constipation
Read More
ALK inhibitor PLB-1003 shows promising results in a phase Ia trial
Read More
ADC Therapeutics studies ADCT-301 for relapsed or refractory Hodgkin's lymphoma in phase II
Read More
Phase III study of CC-486 as maintenance therapy in AML meets primary and key secondary endpoints
Read More
Ritter's phase III trial of RP-G28 for lactose intolerance misses primary endpoint
Read More
Noxxon initiates phase I/II trial of NOX-A12 with radiotherapy for newly diagnosed brain cancer
Read More
Orion Biotechnology obtains Polish clearance to begin phase I study of microbicide gel
Read More